Discovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620710
Title:
Discovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery.
Authors:
March, H Nikki; Chapman, Philip J; Blaikley, Elizabeth; Eberlein, Cath; Cockerill, Mark J; Hitchin, Samantha; Waddell, Ian D; Ogilvie, Donald J
Affiliation:
Cancer Research UK Manchester Institute, Manchester, United Kingdom.
Citation:
Discovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery. 2017, 16(10): Mol Cancer Ther
Journal:
Molecular Cancer Therapeutics
Issue Date:
2017
URI:
http://hdl.handle.net/10541/620710
Type:
Meetings and Proceedings
Language:
en
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorMarch, H Nikkien
dc.contributor.authorChapman, Philip Jen
dc.contributor.authorBlaikley, Elizabethen
dc.contributor.authorEberlein, Cathen
dc.contributor.authorCockerill, Mark Jen
dc.contributor.authorHitchin, Samanthaen
dc.contributor.authorWaddell, Ian Den
dc.contributor.authorOgilvie, Donald Jen
dc.date.accessioned2017-11-27T17:19:56Z-
dc.date.available2017-11-27T17:19:56Z-
dc.date.issued2017-
dc.identifier.citationDiscovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery. 2017, 16(10): Mol Cancer Theren
dc.identifier.urihttp://hdl.handle.net/10541/620710-
dc.language.isoenen
dc.titleDiscovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCancer Research UK Manchester Institute, Manchester, United Kingdom.en
dc.identifier.journalMolecular Cancer Therapeuticsen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.